See Editorial on Page 2062
Chemotherapy-induced hepatitis B reactivation in lymphoma patients with resolved HBV infection: A prospective study
Article first published online: 14 APR 2014
© 2014 by the American Association for the Study of Liver Diseases
Volume 59, Issue 6, pages 2092–2100, June 2014
How to Cite
Hsu, C., Tsou, H.-H., Lin, S.-J., Wang, M.-C., Yao, M., Hwang, W.-L., Kao, W.-Y., Chiu, C.-F., Lin, S.-F., Lin, J., Chang, C.-S., Tien, H.-F., Liu, T.-W., Chen, P.-J., Cheng, A.-L. and on behalf of the Taiwan Cooperative Oncology Group (2014), Chemotherapy-induced hepatitis B reactivation in lymphoma patients with resolved HBV infection: A prospective study. Hepatology, 59: 2092–2100. doi: 10.1002/hep.26718
Potential conflict of interest: Dr. Cheng consults for Eisai and advises Daiichi Sankyo.
This study was supported by grant T1408 from the Taiwan Cooperative Oncology Group of the National Health Research Institutes, Taiwan. The funding source played no direct role in the design and conduct of the study; the collection, management, analysis, and interpretation of the data; or the preparation, review, or approval of the manuscript.
- Issue published online: 28 MAY 2014
- Article first published online: 14 APR 2014
- Accepted manuscript online: 3 SEP 2013 12:05PM EST
- Manuscript Accepted: 23 AUG 2013
- Manuscript Received: 18 APR 2013
Additional Supporting Information may be found in the online version of this article.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.